Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Grover

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Physiology. Heart and Circulatory Physiology|October 2, 2004
Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarctionMichael A Moses, Patrick D Addison, Peter C Neligan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2008
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141Galina Bryzgalova, Suad Effendic, Akhtar Khan, et al.
Journal of Medicinal Chemistry|December 13, 2006
Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptorKonrad Koehler, Sandra Gordon, Peter Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulatorsMark C Manfredi, Yingzhi Bi, Alexandra A Nirschl, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2003
Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liabilityGary J Grover, Karin Mellström, Liu Ye, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 9, 2013
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathwaysDaniel F Vatner, Dirk Weismann, Sara A Beddow, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Physiology. Heart and Circulatory Physiology|October 2, 2004
Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarctionMichael A Moses, Patrick D Addison, Peter C Neligan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2008
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141Galina Bryzgalova, Suad Effendic, Akhtar Khan, et al.
Journal of Medicinal Chemistry|December 13, 2006
Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptorKonrad Koehler, Sandra Gordon, Peter Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulatorsMark C Manfredi, Yingzhi Bi, Alexandra A Nirschl, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2003
Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liabilityGary J Grover, Karin Mellström, Liu Ye, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 9, 2013
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathwaysDaniel F Vatner, Dirk Weismann, Sara A Beddow, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 4